Rouan Sarah Kathryn

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-04-02	2025-03-31	Viking Therapeutics Inc (VKTX)	B Purchase	1,240 +inf% 24.15 USD 29,943	1,240 +inf%	24.15	USD 29,943
2024-10-25	2024-10-25	Viking Therapeutics Inc (VKTX)	PS Planned sale	11,000 -100.0% 80.89 USD 889,790	11,000 -100.0%	80.89	USD 889,790
2024-02-08	2024-02-08	Viking Therapeutics Inc (VKTX)	PS Planned sale	25,000 -100.0% 28.05 USD 701,250	25,000 -100.0%	28.05	USD 701,250
2024-01-19	2024-01-19	Viking Therapeutics Inc (VKTX)	PS Planned sale	30,000 -100.0% 23.05 USD 691,500	30,000 -100.0%	23.05	USD 691,500
2019-05-21	2019-05-17	Navidea Biopharmaceuticals Inc (NAVB)	B Purchase	3,350 +67.0% 1.46 USD 4,904	3,350 +67.0%	1.46	USD 4,904